Two-year results from a randomized, controlled trial in the management of sacroiliac joint dysfunction revealed that SI-BONE’s iFuse yielded more rapid improvements in pain, disability and quality of life vs. non-surgical treatment.
SeaSpine entered into a definitive agreement to acquire NLT Spine, developer of minimally invasive surgery devices. SeaSpine’s commercial launch of the first NLT product is expected in 1H17.
Rotation Medical completed a US $12MM Series B extension financing. Proceeds will support U.S. commercialization of its rotator cuff repair system, comprising a proprietary bioinductive implant and disposable instruments.Â
Centric Medical announced FDA 510(k) clearance of the TARSA-LINKâ„¢ Bunion Correction system, reported to be the first-to-market standalone opening base wedge to feature built-in fixation. Launch is slated for 4Q16.
Zimmer Biomet acquired CD Diagnostics, developer of immunoassays and biomarker testing to inform treatment decisions. Financial terms were not disclosed.